Computational exploration of the self-aggregation mechanisms of phenol-soluble modulins β1 and β2 in Staphylococcus aureus biofilms
Source abstract
Abstract
The formation of functional bacterial amyloids by phenol-soluble modulins (PSMs) in Staphylococcus aureus is a critical component of biofilm-associated infections, providing robust protective barriers against antimicrobial agents and immune defenses. Clarifying the molecular mechanisms of PSM self-assembly within the biofilm matrix is essential for developing strategies to disrupt biofilm integrity and combat biofilm-related infections. In this study, we analyzed the self-assembly dynamics of PSM-β1 and PSM-β2 by examining their folding and dimerization through long-timescale atomistic discrete molecular dynamics simulations. Our findings revealed that both peptides primarily adopt helical structures as monomers but shift to β-sheets upon dimerization. Monomeric state, PSM-β1 exhibited frequent transitions between helical and β-sheet forms, while PSM-β2 largely retained a helical structure. Upon dimerization, both peptides showed pronounced β-sheet formation around conserved C-terminal residues 21-44. Residues 21-33, largely unstructured as monomers, demonstrated strong tendencies for β-sheet formation and intermolecular interactions, underscoring their central role in the self-assembly of both peptides. Additionally, the PSM-β1 N-terminus formed β-sheets only when interacting with the C-terminus, whereas the PSM-β2 N-terminus remained helical and uninvolved in β-sheet formation. These distinct aggregation behaviors likely contribute to biofilm dynamics, with C-terminal regions facilitating biofilm formation and N-terminal regions influencing stability. Targeting residues 21-33 in PSM-β1 and PSM-β2 offers a promising therapeutic approach for disrupting biofilm integrity. This study advances our understanding of PSM-β1 and PSM-β2 self-assembly and presents new targets for drug design against biofilm-associated diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bacterial biofilms and quorum sensing · Biochemical and Structural Characterization · Bacterial Genetics and Biotechnology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules10.1126/science.1173155 ↗
2. Functional amyloids in the human body10.1016/j.bmcl.2021.127914 ↗
3. Half a century of amyloids: past, present and future10.1039/C9CS00199A ↗
4. A new era for understanding amyloid structures and disease10.1038/s41580-018-0060-8 ↗
5. Implications of peptide assemblies in amyloid diseases10.1039/C7CS00372B ↗
6. Amyloid oligomers: a joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis10.1021/acs.chemrev.0c01122 ↗
7. Protein-based biological materials: molecular design and artificial production10.1021/acs.chemrev.2c00621 ↗
8. Protein based biomaterials for therapeutic and diagnostic applications
9. Thermo- and pH-responsive fibrillization of squid suckerin A1H1 peptide10.1039/C9NR09271D ↗
10. Spontaneous formation of beta-sheet nano-barrels during the early aggregation of Alzheimer's amyloid beta10.1016/j.nantod.2021.101125 ↗
11. Misfolding and self-assembly dynamics of microtubule-binding repeats of the Alzheimer-related protein tau10.1021/acs.jcim.1c00217 ↗
12. Molecular insights into the misfolding and dimerization dynamics of the full-length alpha-synuclein from atomistic discrete molecular dynamics simulations10.1021/acschemneuro.2c00531 ↗
13. Small soluble alpha-synuclein aggregates are the toxic species in Parkinson's disease10.1038/s41467-022-33252-6 ↗
14. Amyloid self-assembly of hIAPP8-20 via the accumulation of helical oligomers, alpha-helix to beta-sheet transition, and formation of beta-barrel intermediates
15. Nucleation of beta-rich oligomers and beta-barrels in the early aggregation of human islet amyloid polypeptide10.1016/j.bbadis.2018.11.021 ↗
16. Medin amyloid may drive arterial aging and disease in the periphery and brain10.1038/s43587-023-00481-3 ↗
17. Functional amyloids from bacterial biofilms - structural properties and interaction partners10.1039/D2SC00645F ↗
18. Functional amyloid--from bacteria to humans10.1016/j.tibs.2007.03.003 ↗
19. Effects of pH on aggregation kinetics of the repeat domain of a functional amyloid, Pmel1710.1073/pnas.1006424107 ↗
20. The peptide hormone glucagon forms amyloid fibrils with two coexisting beta-strand conformations10.1038/s41594-019-0238-6 ↗
21. A buried glutamate in the cross-beta core renders beta-endorphin fibrils reversible10.1039/D1NR05679D ↗
22. The three-dimensional structure of human beta-endorphin amyloid fibrils10.1038/s41594-020-00515-z ↗
23. Structural analysis and architectural principles of the bacterial amyloid curli10.1038/s41467-023-38204-2 ↗
24. A multimethod approach for analyzing FapC fibrillation and determining mass per length10.1016/j.bpj.2021.03.031 ↗
25. Cross-talk between individual phenol-soluble modulins in biofilm enables rapid and efficient amyloid formation10.7554/eLife.59776 ↗
26. Staphylococcus epidermidis strategies to avoid killing by human neutrophils10.1371/journal.ppat.1001133 ↗
27. The biofilm matrix10.1038/nrmicro2415 ↗
28. Staphylococcal biofilms
29. Phenol-soluble modulin alpha and beta display divergent roles in mice with staphylococcal septic arthritis10.1038/s42003-022-03839-2 ↗
30. Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype10.1039/C9MD00044E ↗
31. Structure of biofilm-forming functional amyloid PSMalpha1 from Staphylococcus aureus10.1073/pnas.2406775121 ↗
32. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms10.1371/journal.ppat.1002744 ↗
33. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice10.1172/JCI42520 ↗
34. Role of phenol-soluble modulins in Staphylococcus epidermidis biofilm formation and infection of indwelling medical devices10.1016/j.jmb.2019.03.030 ↗
35. How Staphylococcus aureus biofilms develop their characteristic structure10.1073/pnas.1115006109 ↗
36. Solution structures of phenol-soluble modulins alpha1, alpha3, and beta2, virulence factors from Staphylococcus aureus10.1021/acs.biochem.6b00615 ↗
37. Heparin promotes fibrillation of most phenol-soluble modulin virulence peptides from10.1016/j.jbc.2021.100953 ↗
38. Investigating the lytic activity and structural properties of phenol soluble modulin (PSM) peptide toxins10.1016/j.bbamem.2014.08.026 ↗
39. Modulating kinetics of the amyloid-like aggregation of S. aureus phenol-soluble modulins by changes in pH10.3390/microorganisms9010117 ↗
40. Human fibrinogen inhibits amyloid assembly of most phenol-soluble modulins from Staphylococcus aureus10.1021/acsomega.1c02333 ↗
41. Discrete molecular dynamics: an efficient and versatile simulation method for fine protein characterization10.1021/jp2114576 ↗
42. Ab initio folding of proteins with all-atom discrete molecular dynamics10.1016/j.str.2008.03.013 ↗
43. Discrete molecular dynamics simulations of peptide aggregation10.1103/PhysRevE.69.041908 ↗
44. Solving protein structures using short-distance cross-linking constraints as a guide for discrete molecular dynamics simulations10.1126/sciadv.1700479 ↗
45. Highly accurate protein structure prediction with AlphaFold10.1038/s41586-021-03819-2 ↗
46. United-atom discrete molecular dynamics of proteins using physics-based potentials10.1021/ct8003832 ↗
47. MedusaScore: an accurate force field-based scoring function for virtual drug screening10.1021/ci8001167 ↗
48. Eris: an automated estimator of protein stability10.1038/nmeth0607-466 ↗
49. Ab initio RNA folding by discrete molecular dynamics: from structure prediction to folding mechanisms10.1261/rna.894608 ↗
50. Dissecting the Self-assembly Dynamics of Imperfect Repeats in alpha-Synuclein10.1021/acs.jcim.3c00533 ↗
51. Effective energy functions for protein structure prediction10.1016/S0959-440X(00)00063-4 ↗
52. Molecular insights into the effects of F16L and F19L substitutions on the conformation and aggregation dynamics of human calcitonin10.1021/acs.jcim.4c00553 ↗
53. Identifying weak interdomain interactions that stabilize the supertertiary structure of the N-terminal tandem PDZ domains of PSD-9510.1038/s41467-018-06133-0 ↗
54. Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin10.1039/D3SM01332D ↗
55. Structural perturbation of monomers determines the amyloid aggregation propensity of calcitonin variants10.1021/acs.jcim.2c01202 ↗
56. Molecular insights into the oligomerization dynamics and conformations of amyloidogenic and non-amyloidogenic amylin from discrete molecular dynamics simulations10.1039/D2CP02851D ↗
57. Molecular insights into the self-assembly of block copolymer suckerin polypeptides into nanoconfined beta-sheets
58. Computational insights into the aggregation mechanism and amyloidogenic core of aortic amyloid medin polypeptide10.1016/j.colsurfb.2024.114192 ↗
59. Molecular insights into the surface-catalyzed secondary nucleation of amyloid-beta(40) (Abeta(40)) by the peptide fragment Abeta(16-22)10.1126/sciadv.aav8216 ↗
60. Discrete molecular dynamics approach to the study of disordered and aggregating proteins10.1021/acs.jctc.6b01153 ↗
61. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features10.1002/bip.360221211 ↗
62. Peptide folding: when simulation meets experiment10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M ↗
63. Computational investigation of coaggregation and cross-seeding between Abeta and hIAPP underpinning the cross-talk in Alzheimer's disease and type 2 diabetes10.1021/acs.jcim.4c00859 ↗
64. Template induced conformational change of amyloid-beta monomer10.1021/jp300389g ↗
65. SEVI inhibits abeta amyloid aggregation by capping the beta-sheet elongation edges10.1021/acs.jcim.3c00414 ↗
66. The chaperone alphaB-crystallin uses different interfaces to capture an amorphous and an amyloid client10.1038/nsmb.3108 ↗
67. alphaB-crystallin chaperone inhibits abeta aggregation by capping the beta-sheet-rich oligomers and fibrils10.1021/acs.jpcb.0c07256 ↗
68. A comprehensive insight into the mechanisms of dopamine in disrupting abeta protofibrils and inhibiting abeta aggregation10.1021/acschemneuro.1c00306 ↗
69. Mitigation of amyloidosis with nanomaterials
70. Anti-biofilm activity of graphene quantum dots via self-assembly with bacterial amyloid proteins10.1021/acsnano.8b09403 ↗